admin – Page 12 – Swanson Reed | Specialist R&D Tax Advisors

Teeing Up Success: Eastside Golf Secures $3.4M in Seed Funding

Eastside Golf, a burgeoning apparel company based in Wilmington, recently made waves in the industry with the announcement of a significant investment round totaling $3.4 million in seed funding. Led by Elysian Park Ventures (EPV) and PGA of America, this joint venture investment marks a pivotal moment for the company’s growth trajectory.

Founded in 2019 with a mission to promote diversity and youth engagement within the golfing community, Eastside Golf has quickly gained recognition for its innovative approach to sportswear. With a focus on inclusivity and style, the company has garnered attention from both consumers and industry insiders alike.

The infusion of capital from EPV and PGA of America comes at a crucial time for Eastside Golf, allowing the company to bolster its operational capacity and expand its apparel line. Key hires in wholesale management and product development signal the company’s commitment to strategic growth and scalability.

Recognizing the strategic value of its partnership with EPV and PGA of America, Eastside Golf aims to leverage their expertise and resources to drive exponential growth. With a solid foundation in place, the company is poised to capitalize on emerging opportunities in the market.

Looking ahead, Eastside Golf plans to launch a women’s apparel line, tapping into a new market segment while staying true to its core values of inclusivity and accessibility. Additionally, the company will expand its presence with new pop-up shops across the country, enhancing brand visibility and consumer engagement.

Beyond apparel, Eastside Golf is exploring new avenues for growth, including partnerships with athletes and celebrities to broaden its reach and influence. Community outreach initiatives and innovative product offerings further underscore the company’s commitment to driving positive change within the golfing community.

As Eastside Golf sets its sights on the future, the company remains dedicated to pushing the boundaries of traditional sportswear and redefining the golfing experience for a new generation of enthusiasts. With a strong foundation and strategic vision, Eastside Golf is poised to become a leading player in the industry.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Transforming Healthcare: Kilele Health’s Path to Impact

Kilele Health, a pioneering healthcare technology company, recently received a significant boost in funding for its mission to transform healthcare delivery. The company was awarded $1 million in funds from the National Science Foundation.

With a focus on leveraging technology to improve access to healthcare services, Kilele Health is poised to revolutionize the healthcare landscape. The recent funding injection will enable the company to further develop its cutting-edge solutions and expand its reach to underserved communities.

Founded on the principle of making healthcare more accessible and affordable for all, Kilele Health has been at the forefront of research and development in the healthcare technology sector. By harnessing the power of data analytics, artificial intelligence, and telemedicine, the company aims to bridge the gap between patients and healthcare providers.

One of the key areas of focus for Kilele Health is telemedicine, which has emerged as a vital tool in delivering healthcare services remotely. Through its innovative telemedicine platform, Kilele Health enables patients to consult with healthcare professionals from the comfort of their own homes, eliminating the need for costly and time-consuming visits to the doctor’s office.

In addition to telemedicine, Kilele Health is also working on solutions to improve healthcare delivery in rural and underserved areas. By developing mobile health clinics equipped with state-of-the-art medical technology, the company aims to bring essential healthcare services directly to communities that lack access to traditional healthcare facilities.

The $1 million in funding will play a crucial role in advancing Kilele Health’s research and development efforts. With this financial support, the company plans to enhance its existing technologies, develop new innovations, and scale its operations to reach more patients in need.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Empowering Caregivers: Cariloop’s Commitment to Growth and Impact

Cariloop, Inc., a Texas-based caregiver support platform, has raised $20 million during their Series C funding round. Led by ABS Capital and supported by existing investors such as KCRise Fund, the funding is expected to fuel Cariloop’s growth and expand its support solutions, while deepening its ties to communities like Kansas City.

Since its inception, Cariloop has been dedicated to helping families manage their loved ones’ care needs by providing an employer-sponsored, digitally-powered caregiver support platform. With a focus on reducing stress and burnout for caregivers, Cariloop’s comprehensive solution has resonated with corporate investors and companies in Kansas City, driving increased productivity and reduced absenteeism for employers.

Recognizing the significance of local support, Cariloop has made deliberate efforts to partner with Kansas City-based employers and expand its on-the-ground efforts to reach more companies and caregivers in the community. By fostering these partnerships and creating new employment opportunities, Cariloop aims to have a positive economic development impact in Kansas City.

The Series C investment will enable Cariloop to further expand its market reach with employers and caregivers, while also making key investments in its digital and concierge-level offerings. With nearly 75 percent of employees balancing work with caregiving responsibilities, there is a significant opportunity for Cariloop to provide critical support to one of the largest employee population groups.

Cariloop’s revenue growth of nearly 300 percent over the last three years is a testament to the effectiveness of its solutions, landing the company on prestigious lists such as the Inc. 5000 and Deloitte Technology Fast 500. By working with employers of all sizes and industries, Cariloop aims to relieve the stress and anxiety felt by all caregivers, regardless of their career path or geographical location.

As Cariloop continues to grow, it remains committed to fulfilling KCRise Fund’s early and continued expectations, while keeping its focus on attracting top talent from the Kansas City talent pool. By serving more companies and caregivers in the community, Cariloop is making a meaningful impact on the lives of caregivers and their families, one partnership at a time.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Revolutionizing Displays: NanoPattern’s Quantum Dot Ink Secures New Seed Funding

NanoPattern Technologies, Inc., led by cofounders Yu Kambe and Dmitri Talapin, has secured $1.5 million in a seed funding round. The funding will help to scale its photopatternable quantum dot ink, which enables the commercialization of next-generation displays.

The photopatternable quantum dot ink developed by NanoPattern is a game-changer for display component manufacturers. It facilitates the production of full-color microdisplays for a wide range of applications, including augmented reality, virtual reality, wearables, smartphones, tablets, and televisions.

This latest funding round follows a series of strategic investments, including support from the Polsky Center’s George Shultz Innovation Fund and grants from the National Science Foundation’s Small Business Innovation Research program. These investments have been instrumental in fueling NanoPattern’s research and development efforts, allowing the company to demonstrate the effectiveness and reliability of its quantum dot ink.

Partnering with Nanosys Shoei, the world’s largest quantum dot manufacturer, NanoPattern has successfully showcased sub-10 micron pixel resolution, paving the way for widespread adoption of its technology. With the new funding, the company plans to transition from product demonstration to showcasing product-specific features while enhancing quantity control and manufacturing capabilities.

Expansion into a cleanroom environment is also on the agenda for NanoPattern, highlighting the company’s commitment to maintaining rigorous quality standards. Leveraging the advantages of the Chicago area ecosystem, including access to cleanrooms and top talent from local universities, NanoPattern is poised for further growth and innovation.

The successful seed round, led by Queen City Angels and supported by other prominent investors, is a testament to NanoPattern’s potential to disrupt the display industry. With plans to expand its team and attract top talent to the Midwest, NanoPattern is poised to lead the charge in advancing display technology and driving innovation in the region.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Gaining Ground: Arbutus Biopharma and Genevant Sciences in Patent Battle with Moderna

In the ongoing saga of patent disputes surrounding COVID-19 vaccines, Arbutus Biopharma Corporation and Genevant Sciences have made strides in their legal battle against Moderna. With a recent court order clarifying key terms of the patents in question, the two companies are making strides in their quest to claim their share of the profits from Moderna’s Spikevax vaccine.

Arbutus and Genevant initially asserted their patents in 2022, alleging that Moderna utilized their groundbreaking lipid nanoparticle (LNP) delivery platform without proper compensation or licensing. Now, with a joint claim construction brief filed and a detailed court order dissecting the language and scientific intricacies of the patents, the plaintiffs are bolstering their case against Moderna.

Judge Mitchell S. Goldberg’s order largely favors Arbutus and Genevant, rejecting many of Moderna’s proposed constructions and strengthening the plaintiffs’ position. The companies seek compensation for their patented technology, which they argue played a crucial role in the success of Moderna’s COVID-19 vaccine.

While Moderna maintains that its Spikevax technology is the result of independent research and development, Arbutus and Genevant remain steadfast in their commitment to protecting their intellectual property. Interim CEO Michael J. McElhaugh expressed satisfaction with the court’s rulings and emphasized the importance of defending their patents.

The legal battle between the parties is expected to continue for at least two more years, with both sides gearing up for trial. Moderna faces similar lawsuits from other biopharmaceutical companies, underscoring the complexity of intellectual property disputes in the pharmaceutical industry.

Despite the financial success of Spikevax in previous years, sales have been impacted by waning demand and competition from newer boosters. Nevertheless, Arbutus and Genevant’s pursuit of fair compensation for their patented technology remains unwavering.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Revolutionizing Mortgage Technology: Aidium’s $19 Million Series A Funding

Aidium, Inc., a leading player in the mortgage technology sector, has announced the completion of its $19 million Series A funding round led by PeakSpan Capital.

In a mortgage market marked by challenges, this substantial investment not only underscores PeakSpan’s confidence in Aidium’s mission but also highlights the intrinsic value of its solutions.

In today’s evolving mortgage landscape, loan officers face a critical choice: embrace advanced technological solutions or risk falling behind. PeakSpan Capital’s PropTech team recognizes the pivotal role of next-generation CRM platforms integrated with sales and marketing automation. Aidium stands out as a frontrunner in providing comprehensive solutions for mortgage lenders.

Under the visionary leadership of CEO Spencer Dusebout, Aidium is committed to equipping mortgage lenders with a unified platform that streamlines borrower engagement from start to finish. The platform boasts features such as business intelligence/reporting, data warehousing, pipeline management, and enterprise-grade permissioning, addressing critical market needs with an intuitive interface and robust integration capabilities.

Spencer Dusebout, CEO of Aidium, expressed his excitement about the partnership with PeakSpan Capital, emphasizing the validation of their commitment to innovation and vision for transforming the mortgage industry.

The Series A funding infusion will enable Aidium to further enhance its platform, expand its customer base, and solidify its leadership position in the mortgage technology landscape. With a focus on simplifying processes, driving ROI for clients, and providing unmatched customer support, Aidium is poised for rapid growth and sustained success.

Kyle Reitinger, Vice President of PeakSpan, echoed the sentiment, emphasizing Aidium’s ability to scale revenue and roll out powerful new data products despite the challenges in the mortgage environment. The investment signifies a tremendous opportunity for further innovation in the category, and PeakSpan is committed to supporting Aidium in the years ahead.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

KODE Labs Secures $30M Series B Funding

Detroit-based autonomous smart building startup KODE Labs announced the successful closure of a robust $30 million Series B funding round. Spearheaded by Maverix Private Equity and joined by esteemed partners TELUS Ventures and existing investor I Squared Capital, this investment marks a pivotal moment for KODE Labs, propelling its mission to help buildings worldwide achieve net-zero emissions.

Founded in October 2017 by brothers Edi and Etrit Demaj, alongside Gentrit Gojani, KODE Labs has swiftly emerged as a frontrunner in the realm of smart building technology. Recognizing buildings as a major contributor to global carbon emissions, the company is dedicated to enhancing the intelligence, health, and efficiency of buildings, enriching the experiences of occupants and visitors alike.

At the heart of KODE Labs’ innovation lies its enterprise platform, a sophisticated solution that integrates data from diverse building management systems, IoT devices, and operational systems into a unified, cloud-based infrastructure. This seamless integration enables KODE Labs to standardize and organize data at scale, positioning the company as a trailblazer in AI technology tailored for buildings.

With a proven track record of reducing energy consumption and carbon emissions by up to 30%, KODE Labs’ platform has garnered acclaim from Fortune 500 corporations, retailers, financial institutions, and global REITs across various sectors. By prioritizing user experience and operational excellence, KODE Labs has established itself as a leader in sustainable real estate management.

The Series B funding will fuel KODE Labs’ expansion and AI development efforts, enabling the company to further innovate building operations and experiences. By analyzing vast amounts of data, KODE Labs aims to create buildings that prioritize human experience and environmental impact, envisioning a future where efficiency meets human-centric design.

Since its inception, KODE Labs has forged partnerships with renowned companies such as QuadReal, Bedrock Detroit, Stream Realty, Hines, Ford, and other global corporations and REITs. With this latest investment, KODE Labs is poised to accelerate its expansion across North America, Europe, and Australia, solidifying its position as a driving force in the transition towards sustainable real estate management.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Streamlining Video Podcast Production: The Rise of PodcastVideos.com

Podcasting has rapidly grown in popularity in the past few years. Every day we see new podcast ideas popping up, from celebrity talk shows to fitness advice to true crime. PodcastVideos.com is working to meet the needs of these creators, deleting friction from the production and distribution of video podcasts.

Founded by entrepreneur Eric Howerton, the company is reshaping the podcasting landscape by offering professional-level studios and turnkey services tailored to creators of all levels, from aspiring podcasters to Fortune 500 companies.

With PodcastVideos.com, anyone with a podcast idea can book recording time at one of their state-of-the-art studios, starting at an accessible price point. For a comprehensive package including audio and video recording, editing, custom intros, and social media teasers, creators can opt for a membership plan, ensuring a seamless experience from start to finish.

What sets PodcastVideos.com apart is its commitment to quality and convenience. The company boasts five studios with different configurations, equipped with pre-lit setups and screens for presentations or branding. Moreover, their efficient workflow ensures a swift turnaround time, with the goal of delivering the final product within 48 hours of production.

Beyond production, PodcastVideos.com offers support in distribution and promotion, helping creators reach their audience across various platforms such as Apple, Google, YouTube, and more. By providing guidance on search engine optimization and marketing strategies, the company empowers creators to maximize their reach and potentially secure sponsorships.

While PodcastVideos.com caters primarily to businesses and professionals, its versatility extends to personal projects as well. From corporate podcasts to family vacation recaps, the studio serves as a creative hub where ideas come to life. This inclusive approach reflects Howerton’s entrepreneurial spirit, honed through years of experience with ventures like “Get Out” magazine and the creative agency WhyteSpyder.

As PodcastVideos.com continues to expand its footprint, with plans to scale into larger metro markets, it represents a beacon of innovation in the podcasting realm. With a bootstrapped foundation and a vision for growth, Howerton’s venture is poised to redefine the way video podcasts are created, shared, and experienced in the digital age.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Nectero Medical Secures Funds in Fight Against Advancing Abdominal Aortic Aneurysm

Nectero Medical Inc., a pioneering medical technology company based in Tempe, Arizona, has reached a significant milestone in its mission to revolutionize the treatment of abdominal aortic aneurysm (AAA). With the successful closure of a $96 million Series D financing round, Nectero is poised to accelerate the development of its innovative abdominal aortic aneurysm treatment.

Led by Norwest Venture Partners, the Series D round saw substantial contributions from renowned firms such as Boston Scientific, BioStar Capital, Cadence Healthcare Ventures, and Aphelion Capital. This substantial investment will propel Nectero’s Phase II/III stAAAble trial forward and support the submission of an FDA new drug application for its groundbreaking Nectero EAST system.

The Nectero EAST system represents a new approach to AAA treatment, offering a minimally invasive solution with the potential to transform patient outcomes. Designed as an endovascular aneurysm stabilization treatment, EAST features a dual-balloon delivery catheter and a proprietary stabilizer mixture containing pentagalloyl glucose (PGG). This innovative approach strengthens the aortic vessel wall by delivering PGG locally into the aneurysmal wall, reducing the risk of further degradation and rupture.

One of the key advantages of the EAST system is its simplicity and efficiency. The procedure requires no specialized tools and can be completed in less than an hour, offering a streamlined alternative to traditional open surgery. Moreover, EAST leaves behind no permanent implant and does not preclude future interventions, providing patients with a versatile and effective treatment option.

With FDA fast track designation granted last August, Nectero is well-positioned to accelerate the development and regulatory approval of its groundbreaking technology. The addition of Dr. Zack Scott and Dr. Alan Davis to the Nectero board of directors further strengthens the company’s leadership team, bringing invaluable expertise and insight to guide its future growth and success.

AAA poses a significant health risk, affecting approximately 1.4% of individuals aged 50 to 84 in the United States. With aging, tobacco use, and certain medical conditions contributing to the weakening of the aorta’s wall, the need for innovative treatment options is more pressing than ever. Nectero’s commitment to advancing AAA treatment represents a beacon of hope for patients and healthcare providers alike, offering the promise of improved outcomes and enhanced quality of life.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Manifold Bio Secues $15M in Series A Funding

Massachusetts-based startup, Manifold Bio, has secured $15 million in funding to continue research into leveraging artificial intelligence to revolutionize cancer studies. The Series A funding round was led by TQ Ventures and saw participation from new investors including Calibrate Ventures and SK Ventures.

With a mission to modernize the tech infrastructure of clinical research organizations, Manifold Bio has developed an AI-based platform that streamlines manual workflows and reduces administrative burdens for cancer centers. This platform, known as the mDesign™ Platform, accelerates the time to insights from months to minutes, marking a significant advancement in cancer research.

Vinay Seth Mohta, CEO and co-founder of Manifold Bio, highlights the critical need for such innovation in healthcare. By moving away from legacy technologies like Excel spreadsheets, Manifold Bio aims to provide researchers with a purpose-built tech infrastructure that enhances efficiency and productivity.

Supported by this latest funding round, Manifold Bio is poised to expand its partnerships with healthcare organizations and invest in research and development to further enhance its platform’s capabilities. Early adopters, including Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University, have already witnessed the transformative impact of Manifold Bio’s technology.

One of the key features of Manifold Bio’s platform is its ability to unify vast amounts of healthcare data into a single platform, facilitating seamless collaboration and data analysis. This not only accelerates research studies but also reduces costs and manual efforts associated with traditional research workflows.

Anna Maria Storniolo, M.D., medical director at IU Melvin and Bren Simon Comprehensive Cancer Center, praises Manifold Bio’s platform as a game-changer in cancer research. With the ability to respond to research requests in minutes rather than weeks, researchers can now conduct studies with unprecedented speed and efficiency.

Looking ahead, Manifold Bio remains committed to pushing the boundaries of AI technology in healthcare. With a focus on advancing data curation and analysis, Manifold Bio aims to empower researchers with even more advanced tools and capabilities in the near future.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

Schedule a Teleconference

directive for LBI taxpayers